Disclosure Of First-Time Adoption [Text Block]

ChemoMetec - Filing #1269875

Concept	As at 2024-06-30	2023-07-01 to 2024-06-30	2023-07-01 to 2024-06-30	As at 2024-06-30	2023-07-01 to 2024-06-30	As at 2024-06-30	2023-07-01 to 2024-06-30	As at 2024-06-30	2023-07-01 to 2024-06-30	As at 2024-06-30	As at 2023-07-01	As at 2023-07-01	As at 2023-07-01	As at 2023-07-01	As at 2023-07-01	As at 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30	As at 2023-06-30	As at 2023-06-30	2022-07-01 to 2023-06-30	2022-07-01 to 2023-06-30	As at 2023-06-30	2022-07-01 to 2023-06-30	As at 2023-06-30	As at 2022-07-01	As at 2022-07-01	As at 2022-07-01	As at 2022-07-01	As at 2022-07-01
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	69,600 DKK	—	—	478,292 DKK	—	22,000 DKK	—	565,316 DKK	—	17,402 DKK	104,415 DKK	18,000 DKK	411,207 DKK	17,402 DKK	533,042 DKK	18,000 DKK	—	—	104,415 DKK	411,207 DKK	—	—	533,042 DKK	—	17,402 DKK	- DKK	357,205 DKK	339,777 DKK	26,000 DKK	17,402 DKK
Comprehensive income	—	69,600 DKK	- DKK	—	67,085 DKK	—	4,000 DKK	—	136,689 DKK	—	—	—	—	—	—	—	104,415 DKK	71,497 DKK	—	—	8,000 DKK	- DKK	—	175,904 DKK	—	—	—	—	—	—
Profit (loss)	—	69,600 DKK	- DKK	—	66,684 DKK	—	- DKK	—	136,284 DKK	—	—	—	—	—	—	—	104,415 DKK	74,252 DKK	—	—	- DKK	- DKK	—	178,667 DKK	—	—	—	—	—	—